These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 954351

  • 1. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M.
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [Abstract] [Full Text] [Related]

  • 2. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM, Lelorier J.
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [Abstract] [Full Text] [Related]

  • 3. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA, Reid PR.
    N Engl J Med; 1978 May 25; 298(21):1160-3. PubMed ID: 651945
    [Abstract] [Full Text] [Related]

  • 4. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
    Zito RA, Reid PR.
    J Clin Pharmacol; 1981 May 25; 21(2):100-5. PubMed ID: 7229115
    [Abstract] [Full Text] [Related]

  • 5. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
    Pomier-Layrargues G, Huet PM, Villeneuve JP, Marleau D.
    Gastroenterology; 1986 Jul 25; 91(1):163-7. PubMed ID: 3710065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND, Tucker GT, Woods HF.
    Br J Clin Pharmacol; 1980 Oct 25; 10(4):353-61. PubMed ID: 7448106
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.
    Gremse DA, Sindel LJ, Hoff CJ, Wells DJ, Boerth RC.
    J Pediatr Gastroenterol Nutr; 2001 Apr 25; 32(4):434-7. PubMed ID: 11396809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS, Tsai YT, Kong CW, Lee FY, Chang TT, Lin HC, Yang CM, Lee SD, Chiang BN, Lo KJ.
    Clin Pharmacol Ther; 1988 Oct 25; 44(4):453-7. PubMed ID: 3168396
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT, Marigold JH, Thompson RP.
    Hepatogastroenterology; 1982 Apr 25; 29(2):55-7. PubMed ID: 7084884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND, Tucker GT, Lennard MS, Woods HF.
    Br J Clin Pharmacol; 1985 May 25; 19(5):597-603. PubMed ID: 2860914
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.